Sigmak Lifesciences supports pharmaceutical manufacturers, importers, and distributors in Egypt with WHO-GMP sourced injectable formulations, active pharmaceutical ingredients, and specialty chemical intermediates. Egypt is the largest pharmaceutical market in North Africa, with a strong domestic manufacturing base overseen by the Egyptian Drug Authority (EDA).
The injectable portfolio covers antibiotics, anti-infectives, cardiovascular agents, analgesics, vitamins, and critical care formulations in ampoule, vial, and infusion formats. Documentation packages including COA, COPP, and stability data are available to support EDA registration submissions and import requirements.
Sigmak provides structured supply and documentation support for both private pharmaceutical companies and government procurement programs across Egypt, with a focus on responsive commercial and regulatory assistance.